Skip to content

Improving Patient Experience: BMBA

Improving the Patient Experience During Bone Marrow Biopsy/Aspiration (BMBA): Do Interventions Decrease Distress and Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05690230
Enrollment
60
Registered
2023-01-19
Start date
2022-12-05
Completion date
2024-06-05
Last updated
2025-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Marrow Cancer, Hematologic Cancer, Leukemia, Lymphoma, Multiple Myeloma

Brief summary

This study seeks to determine if patients undergoing a bone marrow biopsy/aspiration (BMBA) procedure who receive distraction techniques have lower levels of distress and pain, and higher post-procedure satisfaction, compared to those receiving standard-of-care. Intervention 1 is guided meditation in a virtual reality (VR) headset. Intervention 2 is comprised of environmental changes to the room (via nature-themed decals) and music.

Detailed description

This study seeks to determine if patients undergoing a bone marrow biopsy/aspiration (BMBA) procedure who receive distraction techniques have lower levels of distress and pain, and higher post-procedure satisfaction, compared to those receiving standard-of-care. Intervention 1 is guided meditation in a virtual reality (VR) headset. Intervention 2 is comprised of environmental changes to the room (via nature-themed decals) and music.

Interventions

OTHERVirtual reality

Patients will be provided with a wireless virtual reality headset that contains a guided meditation application. The application allows users to select their preferred music, visual setting, and a topic for meditation.

OTHEREnvironmental changes

A nature themed wall mural decal will be installed in the procedure room and the in-room computer will play music from Pandora. A selection of suggested stations will be provided, with the option for outside selections.

Sponsors

Daisy Foundation
CollaboratorOTHER
Thomas Jefferson University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Two interventions will be trialed, each in parallel with a control group. The two phases will be done in sequence.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Provide signed and dated informed consent form * Willing to comply with all study procedures * Over 18 years of age * Prior history of at least 1 (one) BMBA at Jefferson outpatient oncology office within the past 2 (two) years * Visiting the Jefferson outpatient oncology office for a BMBA procedure during the study duration

Exclusion criteria

* Inability to read questions in English * Inability to answer questions autonomously * History of vertigo * Legal blindness in both eyes * Severe or profound hearing loss, or deafness

Design outcomes

Primary

MeasureTime frameDescription
Distress scoreWithin 10 minutes pre-procedureThe primary outcome will be reported on a scale of 0-10, based on the National Comprehensive Cancer Network (NCCN) Distress Thermometer, 0 signifying no distress and 10 signifying extreme distress. This scale is standardly used with oncology patients to determine their distress levels-distress refers to an unpleasant experience of a mental, physical, social, or spiritual nature. It can affect the way you think, feel, or act. Distress may make it harder to cope with having cancer, its symptoms, or its treatment.

Secondary

MeasureTime frameDescription
Pain intensityWithin 10 minutes pre-procedureTo assess patient pain scores related to their BMBA procedure. This will be measured through the 0-10 Numeric Pain Intensity Scale, 0 signifying no pain and 10 signifying the worst pain imaginable.
Patient satisfactionWithin 10 minutes post-procedureTo assess patient satisfaction with their procedure. This will be assessed through a patient satisfaction survey including Likert-type questions.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026